Noul Inc. formally signed a strategic partnership agreement with Wezi medical center, one of the largest hospitals in Malawi, Africa. The focus of the agreement revolves around the establishment of Noul's Tropical and Infectious Disease (TID) research center in the Wezi medical center facility. Noul TID's first research mission will focus on increasing the accessibility of accurate Malaria and febrile diseases diagnostics.
“Whereas biotechnology and healthcare are the two high value-added industries, most are focused in advanced countries. Underdeveloped countries barely benefit and our mission is to break the barrier and contribute to those in resource-poor settings through innovative technologies.” “The mission is the driving force to all of our members creating a healthy corporate culture and happiness in life.”
“0.6 - 0.7 million malaria deaths are reported every year, and 90% is from underdeveloped countries in Africa and East Asia.” “This mobile diagnostic device NOUL developed can help reduce the death rates.” “The accuracy of the diagnostics is much higher, not to mention that it is much faster than other existing diagnostic devices, diagnosing within 15 minutes.”
Emphasized the technological breakthrough that “once the chip developed by NOUL enters the underdeveloped countries, it will bring an revolutionary change” and the significance of cutting edge technology in development as “where the laboratory and technology of the advanced countries are most needed is the underdeveloped countries”